COVID 19 AS A TRIGGER FOR THE OCCURRENCE OF STROKE IN UNDIAGNOSED TRANSIENT FORAMEN OVALE AND THROMBOPHILIA
Abstract
Introduction: COVID-19 is an infection caused by the new coronavirus (SARS-CoV-2). The disease is manifested by respiratory symptoms and can cause serious complications, including acute ischemic stroke (AIS).
The objective of the paper is to point out the complexity of risk factor interaction for the development of AIS after COVID-19.
Case report: A 28-year-old man developed AIS two and a half months after COVID-19. The examination of the patient, who was already on anticoagulant therapy for high D-dimer levels, revealed a left-sided weakness. Computed tomography (CT) showed a fresh frontal ischemic lesion. Upon recanalization, the neurological deficit resolved completely. Further studies revealed a patent foramen ovale (PFO) and congenital thrombophilia.
Conclusion: Additional research is necessary to clarify the role of certain risk factors in the development of AIS even in mild cases of COVID-19.
Keywords: COVID-19, AIS, thrombophilia
References
[1] Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, Kaptein FHJ, van Paassen J, Stals MAM, Huisman MV, Endeman H. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020; 191: 145-147. doi: 10.1016/j.thromres.2020.04.013. https://pubmed.ncbi.nlm.nih.gov/32291094/
[2] Frontera JA, Sabadia S, Lalchan R, Fang T, Flusty B, Millar-Vernetti P, Snyder T, Berger S, Yang D, Granger A, Morgan N, Patel P, Gutman J, Melmed K, Agarwal S, Bokhari M, Andino A, Valdes E, Omari M, Kvernland A, Lillemoe K, Chou SH, McNett M, Helbok R, Mainali S, Fink EL, Robertson C, Schober M, Suarez JI, Ziai W, Menon D, Friedman D, Friedman D, Holmes M, Huang J, Thawani S, Howard J, Abou-Fayssal N, Krieger P, Lewis A, Lord AS, Zhou T, Kahn DE, Czeisler BM, Torres J, Yaghi S, Ishida K, Scher E, de Havenon A, Placantonakis D, Liu M, Wisniewski T, Troxel AB, Balcer L, Galetta S. A Prospective Study of Neurologic Disorders in Hospitalized Patients With COVID-19 in New York City. Neurology. 2021; 96(4): 575-586. doi: 10.1212/WNL.0000000000010979.
https://pubmed.ncbi.nlm.nih.gov/33020166/
[3] Avula A, Nalleballe K, Narula N, Sapozhnikov S, Dandu V, Toom S, Glaser A, Elsayegh D. COVID-19 presenting as stroke. Brain Behav Immun. 2020; 87: 115-119. doi: 10.1016/j.bbi.2020.04.077. https://pubmed.ncbi.nlm.nih.gov/32360439/
[4] Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020; 7(6): 438-440. doi: 10.1016/S2352-3026(20)30145-9. https://sci-hub.se/10.1016/S2352-3026(20)30145-9
[5] Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020; 395(10234): 1417-1418. doi: 10.1016/S0140-6736(20)30937-5. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172722/
[6] Wang Z, Yang Y, Liang X, Gao B, Liu M, Li W, Chen Z, Wang Z. COVID-19 Associated Ischemic Stroke and Hemorrhagic Stroke: Incidence, Potential Pathological Mechanism, and Management. Front Neurol. 2020; 11: 571996. doi: 10.3389/fneur.2020.571996. https://sci-hub.se/10.3389/fneur.2020.571996
[7] Tu TM, Seet CYH, Koh JS, Tham CH, Chiew HJ, De Leon JA, Chua CYK, Hui AC, Tan SSY, Vasoo SS, Tan BY, Umapathi NT, Tambyah PA, Yeo LLL. Acute Ischemic Stroke During the Convalescent Phase of Asymptomatic COVID-2019 Infection in Men. JAMA Netw Open. 2021; 4(4): 217498. doi: 10.1001/jamanetworkopen.2021.7498. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063067/
(8) Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome
- Autori zadržavaju autorska prava i pružaju časopisu pravo prvog objavljivanja rada i licenciraju ga "Creative Commons Attribution licencom" koja omogućava drugima da dele rad, uz uslov navođenja autorstva i izvornog objavljivanja u ovom časopisu.
- Autori mogu izraditi zasebne, ugovorne aranžmane za neekskluzivnu distribuciju članka objavljenog u časopisu (npr. postavljanje u institucionalni repozitorijum ili objavljivanje u knjizi), uz navođenje da je članak izvorno objavljen u ovom časopisu.
- Autorima je dozvoljeno i podstiču se da postave objavljeni članak onlajn (npr. u institucionalni repozitorijum ili na svoju internet stranicu) pre ili tokom postupka prijave rukopisa, s obzirom da takav postupak može voditi produktivnoj razmeni ideja i ranijoj i većoj citiranosti objavljenog članka (Vidi Efekti otvorenog pristupa).